CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.35 CNY | +0.13% |
|
-1.15% | +21.20% |
| 29/04 | Kanghong Pharmaceutical's Unit Gets US FDA's Green Light to Test Macular Degeneration Drug | MT |
| 29/04 | Kanghong Pharmaceutical's Unit Gets Nod to Trial Macular Degeneration Drug | MT |
Evolution of the average Target Price on Chengdu Kanghong Pharmaceutical Group Co., Ltd
Price target over the last 5 years
History of analyst recommendation changes
904238cfd508deddc0f431d.dt0CduhLViypm-yGkD4AwUieL8usyVCOxLdRV65tB4Y.Pet3A4sCexX83YPexldyrRrGXo70gCXIqfA2Od04TbIa61FPgDEVSeHfnw~ac8312099da7b2c74cc6e234fb8d462f
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
22.35
Average target price
-
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
D-
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 002773 Stock
- Consensus Chengdu Kanghong Pharmaceutical Group Co., Ltd
